Trial Profile
A randomized, double-blind, parallel group, placebo controlled Phase II study to evaluate the safety and efficacy of two inhaled LASAG regimens and Placebo, applied three times daily in adult hospitalized patients with acute serious influenza
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2015
Price :
$35
*
At a glance
- Drugs Glycine/lysine-acetylsalicylate (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Activaero GmbH; Vectura
- 24 Jan 2013 New trial record